SCHEMBL94233

SCHEMBL94233

CC(C)NC(=O)CCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
FAAH O00519 1/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 1/20 0.54
PHF8 Q9UPP1 6/20 0.50
KDM2A Q9Y2K7 6/20 0.50
KDM4E B2RXH2 4/20 0.50
KDM5C P41229 4/20 0.50
EGLN1 Q9GZT9 4/20 0.50
KDM6B O15054 2/20 0.50
FOLH1 Q04609 1/20 0.50
KDM7A Q6ZMT4 1/20 0.48
LMNA P02545 2/20 0.45
ALKBH5 Q6P6C2 1/20 0.45
SUCNR1 Q9BXA5 1/20 0.45
GNPAT O15228 1/20 0.44
ALDH1A1 P00352 2/20 0.42
SLC15A2 Q16348 1/20 0.42
HPGD P15428 1/20 0.42
GABRP O00591 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5909062 0.89 MEN1 (0.62) MEN1FAAHMAPK1KMT2AKDM4E
SCHEMBL8238806 0.86 MEN1 (0.61) MEN1FAAHMAPK1KMT2ALMNA
SCHEMBL18573663 0.84 MEN1 (0.70) MEN1FAAHMAPK1KMT2ALMNA
SCHEMBL20414825 0.84 MEN1 (0.70) MEN1FAAHMAPK1KMT2ALMNA
SCHEMBL18573713 0.84 MEN1 (0.70) MEN1FAAHMAPK1KMT2ALMNA
SCHEMBL15575426 0.83 PHF8 (0.48) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL19203698 0.82 FOLH1 (0.60) FOLH1GNPAT
SCHEMBL24567749 0.81 PHF8 (0.46) PHF8KDM2AKDM4EKDM5CEGLN1
SCHEMBL4572566 0.81 ALDH1A1 (0.51) FAAHPHF8KDM2AKDM4EKDM5C
SCHEMBL5965457 0.81 PHF8 (0.46) PHF8KDM2AKDM4EKDM5CEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120005237-A Carbon fiber material and preparation method thereof 北华大学 2025-05-16 CN claimed
CN-120005237-A Carbon fiber material and preparation method thereof 北华大学 2025-05-16 CN disclosed
WO-2024151890-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2024-07-18 WO disclosed
US-11753403-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2023-09-12 US disclosed
US-20230063768-A1 IMMUNOPHILIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-03-02 US disclosed
US-20230001001-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-01-05 US disclosed
WO-2022263564-A1 SILOXANE-BASED POLYMERIC MATERIALS FOR EFFICIENT REARRANGEMENT AND CURING REACTIONS AND WITH SPECIFIC DEGREE OF POLYMERIZATION SILOXENE AG (CH) 2022-12-22 WO disclosed
EP-3377492-B1 CATALYST FOR THE PREPARATION OF POLYURETHANES BASF SE (DE) 2022-08-31 EP disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
US-20210393790-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2021-12-23 US disclosed
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
US-20080274965-A1 ENCAPSULATED AMYLOID-BETA PEPTIDES INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
US-20080207561-A1 NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME ALLERGAN, INC. 2008-08-28 US disclosed
US-20080200948-A1 NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME PHOTOBIOMED CORPORATION (US) 2008-08-21 US disclosed
WO-2008094675-A2 NOVEL BIOMATERIALS AND METHODS FOR MAKING AND USING SAME PHOTOBIOMED CORPORATION (US) 2008-08-07 WO disclosed
WO-2008094659-A2 NOVEL BIOMATERIALS FOR OCULAR DRUG DELIVERY AND A METHOD FOR MAKING AND USING SAME ALLERGAN, INC. (US) 2008-08-07 WO disclosed
WO-2007094513-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-23 WO disclosed
US-4921942-A Organometallic compounds STEPAN COMPANY (US) 1990-05-01 US disclosed
US-4724174-A AMIDO CARBOXYL SOAPS; FILM-FORMING; SUBSTANTIVITY STEPAN COMPANY (US) 1988-02-09 US disclosed
US-4675422-A ALUMINUM COATINGS STEPAN COMPANY (US) 1987-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274965-A1 ENCAPSULATED AMYLOID-BETA PEPTIDES IAPP, APP, TTR MEN1 227/4885FAAH 1917/4885MAPK1 4609/4885
US-20230001001-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE CD4, MCL1, CCNB1 MEN1 106/4885FAAH 3316/4885MAPK1 1789/4885
US-20230063768-A1 IMMUNOPHILIN BINDING AGENTS AND USES THEREOF PMP22, MAG, FABP7 MEN1 2204/4885FAAH 901/4885MAPK1 4798/4885
US-20210393790-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE CD4, MCL1, CCNB1 MEN1 106/4885FAAH 3316/4885MAPK1 1789/4885
US-11753403-B2 EIF4E inhibitors and uses thereof EIF4E, EIF4EBP1, EIF4A1 MEN1 2104/4885FAAH 4657/4885MAPK1 1701/4885
US-20080200948-A1 NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME MMP1, PLOD3, MMP2 MEN1 2837/4885FAAH 925/4885MAPK1 4832/4885
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery CLTB, SLC1A5, CLTA MEN1 2136/4885FAAH 1715/4885MAPK1 4597/4885
US-20080207561-A1 NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME PTGES, PTGES2, PTGIS MEN1 4526/4885FAAH 1766/4885MAPK1 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.